Journal of Research in Medical Sciences

ORIGINAL ARTICLE
Year
: 2022  |  Volume : 27  |  Issue : 1  |  Page : 48-

Body composition and serum levels of matrix metalloproteinase-9, adiponectin and AMP-activated protein kinase in breast cancer survivors


Zeinab Babaei1, Hadi Parsian2, Bahare Korani3, Amrollah Mostafazadeh2, Dariush Moslemi4 
1 Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
2 Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
3 Department of Clinical Biochemistry, School of Medical Science, Tarbiat Modares University, Tehran, Iran
4 Department of Radiooncology, Babol University of Medical Sciences, Babol, Iran

Correspondence Address:
Dr. Dariush Moslemi
Department of Radiooncology, Babol University of Medical Sciences, Babol
Iran

Background: Available data suggest that obesity is related to changes in the several adipocyte-derived proteins levels, which are involved in cancer recurrence. The purpose of this work was to investigate the correlation between obesity with metalloproteinase-9 (MMP-9), adiponectin and adiponectin and AMP-activated protein kinase (AMPK) levels by comparing serum levels of MMP-9, AMPK in normal weight and obese breast cancer survivors. Materials and Methods: In this cross-sectional study, 30 normal weight breast cancer survivors (body mass index [BMI] 18.5-25 kg/m2) and 30 obese breast cancer survivors (BMI ≥30 kg/m2) were investigated. Anthropometric parameters and serum levels of MMP-9, adiponectin, and AMPK were compared between the two groups. Results: No differences were detected in the serum levels of MMP-9, adiponectin, and AMPK in obese patients and normal weight patients (P > 0.05). There were no correlations between MMP-9, adiponectin, and AMPK levels with anthropometric measurements in two groups (P > 0.05). Conclusion: We found that there was a lack of correlation between obesity measures and serum levels of MMP-9, adiponectin, and AMPK. In breast cancer survivors, it seems that circulating levels of adiponectin, AMPK, and MMP-9 do not change in obesity state.


How to cite this article:
Babaei Z, Parsian H, Korani B, Mostafazadeh A, Moslemi D. Body composition and serum levels of matrix metalloproteinase-9, adiponectin and AMP-activated protein kinase in breast cancer survivors.J Res Med Sci 2022;27:48-48


How to cite this URL:
Babaei Z, Parsian H, Korani B, Mostafazadeh A, Moslemi D. Body composition and serum levels of matrix metalloproteinase-9, adiponectin and AMP-activated protein kinase in breast cancer survivors. J Res Med Sci [serial online] 2022 [cited 2022 Oct 3 ];27:48-48
Available from: https://www.jmsjournal.net/article.asp?issn=1735-1995;year=2022;volume=27;issue=1;spage=48;epage=48;aulast=Babaei;type=0